BML-284 is a compound that interferes with the Wnt signaling pathway, which plays a key role in regulating cell proliferation, migration, and differentiation.
Molecular Weight
350.37
Molecular Formula
C19H18N4O3
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
BML-284 is a Wnt inhibitor studied for modulating Wnt/β-catenin signaling, impacting cancer research.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
